Avania today said it has acquired medical device clinical research IMARC for an undisclosed amount.
Strongsville, Ohio-based IMARC is a full-service clinical research oversight company that offers monitoring, auditing, safety, data management and training.
“At Avania, we are focused on building a high-quality, full-service specialist medical technology CRO with global reach,” Avania CEO Sapna Hornyak said in a news release. “We are delighted to welcome the IMARC team, with whom we have had the pleasure of collaborating for some time. They bring a great commitment to client service and outcomes and allow us to offer our clients additional depth and strength in the United States, complementing our existing global operations perfectly.”
Through the deal, IMARC’s clients will gain access to Avania’s extended international footprint in the EU and Australia. Netherlands-based Avania will also provide its biostatistics, strategic consulting, regulatory and medical writing.
“Avania’s geographic and therapeutic area strengths make them the perfect strategic complement to IMARC,” IMARC CEO Sandra Maddock said. “Adding IMARC’s portfolio of capabilities to Avania’s will provide clients with a single-source provider of extensive, specialized medical device expertise combined with global reach.”